Skip to main content

Retinal Tolerance of Intravitreal Low-Molecular-Weight Heparin, Colchicine or Interferon ß Determined by Eye-Cup ERG in Albino Rabbits

  • Chapter

Abstract

We investigated the effects of the following drugs on the eye-cup electroretinogram in albino rabbits: low-molecular-weight heparin to treat inflammation, colchicine to prevent postoperative cellular proliferation in the vitreous cavity and interferon ß for antiviral treatment. The a- and b-waves and the oscillatory potentials were unchanged during perfusion with 5 and 20 IU/ml low-molecular-weight heparin, 25 and 50 µg/ml colchicine or 5,000 and 10,000 IU/ml interferon ß. Potential clinical intravitreal use of low-molecular-weight heparin and interferon ß was suggested, respectively, for prophylaxis of postoperative intraocular fibrin reactions and proliferative vitreoretinopathy, and to treat viral retinitis.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. M. Lemor, S. de Bustros, and B. M. Glaser, Low-dose colchicine inhibits astrocyte, fibroblast, and retinal pigment epithelial cell migration and proliferation, Arch. Ophthalmol 104: 1223 (1986).

    Article  PubMed  CAS  Google Scholar 

  2. M. Lemor, J. H. Jeo, and B. M. Glaser, Oral colchicine for the treatment of experimental traction retinal detachment, Arch. Ophthalmol. 104: 1226 (1986).

    Article  PubMed  CAS  Google Scholar 

  3. N. Ishida, Strategies for antiviral chemotherapy, Atarashii Ganka 9:173 (1992).

    Google Scholar 

  4. Y. Ohashi, T. Sasabe, T. Nishida, and R. Manabe, Natural killer cells kill human retinoblastma cells, Jpn. J. Ophthalmol. 28: 370 (1984).

    PubMed  CAS  Google Scholar 

  5. T. Yokoyama, O. Yoshie, H. Aso, T. Ebina, N. Ishida, and K. Mizuno, Role of natural killer cells in intraocular melanoma metastasis, Invest. Ophthalmol. Vis.Sci. 27: 516 (1986).

    PubMed  CAS  Google Scholar 

  6. S. Hamano, M. Kinukawa, H. Komatsu, S. Ikeda, and N. Sakuragawa, Effects of low molecular weight heparin (FR-860) on coagulative and fibrinolytic activities, Folia Pharmacol. Japon 94: 243 (1989).

    Article  CAS  Google Scholar 

  7. M. S. Blumenkranz, M. K. Hartzer, and D. Iverson, An overview of potential applications of heparin in vitreoretinal surgery, Retina 12: S71 (1992).

    Article  PubMed  CAS  Google Scholar 

  8. R. N. Johnson, and G. Blankenship, A prospective, randomized, clinical trial of heparin therapy for postoperative intraocular fibrin, Ophthalmology 95: 312 (1988).

    PubMed  CAS  Google Scholar 

  9. D. A. Iverson, H. Katsura, M. K. Hartzer, and M. S. Blumenkranz, Inhibition of intraocular fibrin formation following infusion of low-molecular-weight heparin during vitrectomy, Arch.Ophthalmol. 109: 405 (1991).

    Article  PubMed  CAS  Google Scholar 

  10. H. Kondo, H. Hayashi, and K. Oshima, Fibrin prophylaxis with low molecular weight heparin during intraocular surgery, Jpn. J. Ophthalmic Surg. 6: 597 (1993).

    Google Scholar 

  11. J. N. P. Kirkpatrick, A. D. Dick, and J. V. Forrester, Clinical experience with interferon alfa-2a for exudative age-related macular degeneration, Br. J. Ophthalmol. 77: 766 (1993).

    Article  PubMed  CAS  Google Scholar 

  12. S. Vegh, J. Vernot, G. A. Peyman, and R. Fiscella, Toxicity of intravitreal interferon, OphthalmicSurg. 17: 103 (1986).

    PubMed  CAS  Google Scholar 

  13. S. K. Dharma, G. A. Peyman, J. Vernot, and R. Fiscella, Toxicity of intravitreally administered alpha-interferon, Ophthalmic Surg. 18: 51 (1987).

    PubMed  CAS  Google Scholar 

  14. M. A. Karaçorlu, G. A. Peyman, S. Cruz, K. F. Soike, Lack of toxicity of intravitreally administered interferon alpha-2a, Ophthalmic Surg. 23: 833 (1992).

    PubMed  Google Scholar 

  15. K. Ohki, G. A. Peyman, A. Candel, and R. Fiscella, Toxicity of intravitreal interferon in combination with acyclovir after lensectomy and vitrectomy, Folia Ophthalmol. Jpn. 38: 158 (1987).

    Google Scholar 

  16. D. H. Berman and G. M. Gombos, Proliferative vitreoretinopathy: Does oral low-dose colchicine have an inhibitory effect? A controlled study in humans, Ophthalmic Surg. 20: 268 (1989).

    PubMed  CAS  Google Scholar 

  17. J. O. Karlsson, H. A. Hansson, and J. Sjöstrand, Effect of colchicine on axonal transport and morphology of retinal ganglion cells, Z. Zeilforsch. 115: 265 (1971).

    Article  Google Scholar 

  18. O. L. Vaccarezza, E. Pasqualini, and J. P. Saavedra, Retinal alterations induced by intravitreous colchicine, Virchows Arch.Abt.B Zellpath. 12: 159 (1973).

    CAS  Google Scholar 

  19. C. Davidson, W. R. Green, and V. G. Wong, Retinal atrophy induced by intravitreous colchicine,Invest. Ophthalmol. Vis.Sci. 24: 301 (1983).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Yamashita, Y., Mochizuki, K., Sakai, H., Torisaki, M., Tanabe, J. (1995). Retinal Tolerance of Intravitreal Low-Molecular-Weight Heparin, Colchicine or Interferon ß Determined by Eye-Cup ERG in Albino Rabbits. In: Weisse, I., Hockwin, O., Green, K., Tripathi, R.C. (eds) Ocular Toxicology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1887-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1887-7_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5769-8

  • Online ISBN: 978-1-4615-1887-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics